Julian Jenkins Joins Clinical Leader Editorial Advisory Board
By Ed Miseta, Chief Editor, Clinical Leader
Erie, PA – Dr. Julian Jenkins, VP and Head of Innovation, Performance and Technology within the Projects, Clinical Platforms & Sciences (PCPS) group in GSK Pharma R&D, has agreed to join the Editorial Advisory Board for Clinical Leader. In his current role, Dr. Jenkins is accountable for performance management, business strategy and operations, and change management for PCPS, while maintaining a state of the art clinical and project technology infrastructure for the Pharma clinical organization. He also leads the innovation agenda for the platform, which is focused on harnessing digital technologies to transform the way clinical trials are conducted at GSK.
He is a medicine mentor and participates in many project and study level peer review activities, and serves on a number of governance committees within R&D. He is a member of the Transcelerate Biopharma operations committee, and sponsors the eSource project within GSK.
Jenkins has been with GSK for more than 18 years. Previous roles in discovery and development have included leadership of clinical development organizations and projects from candidate selection to market, and as a clinical scientist and leader in clinical pharmacology. He has published extensively in the areas of oncology, hematology and infectious disease drug development. Jenkins has a BSc in Biological Sciences (University of Wolverhampton) and a MSc in Clinical Virology (University of Surrey). He obtained his Ph.D in Cardiovascular Medicine from the University of Nottingham Medical School in the UK.
Clinical Leader, part of the Life Science Connect Media Group, is the pharmaceutical industry’s leading online resource for clinical trial analysis and opinion. With the goal of streamlining the clinical research process by connecting trial sponsors with cutting edge service providers, Clinical Leader facilitates connections and collaborations by providing valuable information on CROs, sponsors, and advancements in clinical trials. The entire Editorial Advisory Board can be seen here.
For more information:
Ed Miseta, Chief Editor
(814) 897-7700 ext. 179
ed.miseta@lifescienceconnect.com
Twitter: @EdClinical